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Abstract 
Hedgehog signaling is a pivotal developmental pathway that comprises hedgehog, 
PTCH1, SMO, and GLI proteins. Mutations in PTCH1 are responsible for Gorlin 
syndrome, which is characterized by developmental defects and tumorigenicity. 
Although the hedgehog pathway has been investigated extensively in Drosophila and 
mice, its functional roles have not yet been determined in human cells. In order to 
elucidate the mechanism by which transduction of the hedgehog signal is regulated in 
human tissues, we employed human fibroblasts derived from three Gorlin syndrome 
patients and normal controls. We investigated GLI1 transcription, downstream of 
hedgehog signaling, to assess native signal transduction, and then treated fibroblasts 
with a recombinant human hedgehog protein with or without serum deprivation. We 
also examined the transcriptional levels of hedgehog-related genes under these 
conditions. The expression of GLI1 mRNA was significantly higher in Gorlin 
syndrome-derived fibroblasts than in control cells. Hedgehog stimulation and nutritional 
deprivation synergistically enhanced GLI1 transcription levels, and this was blocked 
more efficiently by vismodegib, a SMO inhibitor, than by the natural compound, 
cyclopamine. Messenger RNA profiling revealed the increased expression of Wnt 
signaling and morphogenetic molecules in these fibroblasts. These results indicated that 
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the hedgehog stimulation and nutritional deprivation synergistically activated the 
hedgehog signaling pathway in Gorlin syndrome fibroblasts, and this was associated 
with increments in the transcription levels of hedgehog-related genes such as those 
involved in Wnt signaling. These fibroblasts may become a significant tool for 
predicting the efficacies of hedgehog molecular-targeted therapies such as vismodegib. 
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1. Introduction 
Hedgehog signaling is a pivotal developmental pathway that comprises hedgehog, 
patched, smoothened, and gli proteins [1]. The hedgehog gene was first identified in 
Drosophila as a segment polarity gene that controls the segmental pattern of the embryo 
[2]. Hedgehog signaling is known to be crucially involved in morphogenesis, 
tumorigenesis, osteoblast differentiation, wound repair, and neuroprotection [3,4]. 
PTCH, the human homolog of Drosophila patched, is a twelve-pass transmembrane 
protein coding a receptor for hedgehog that constitutively suppresses activation of the 
hedgehog pathway by inhibiting SMO, which transmits hedgehog signaling. When 
hedgehog ligands bind to PTCH, the inhibition of SMO is released and SMO then 
activates GLI through several cytoplasmic transduction steps, leading to the 
translocation of GLI into the nucleus and expression of the targeted gene [5]. 
Gorlin syndrome (GS) is a rare autosomal dominant disease that is characterized by 
developmental anomalies including palmer and plantar pits, skeletal abnormalities, falx 
calcification, and tumorigenesis such as basal cell carcinoma (BCC), ketatocystic 
odontogenic tumors, and medulloblastoma [6]. This syndrome is caused by mutations in 
PTCH1, and more than 200 mutations have been reported to date [7].  
Tumorigenesis is a lifelong problem in patients with GS. These patients develop 
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BCCs in their early 20s, with more than 80% of patients having one or more BCCs 
throughout their lifetime. Medulloblastoma occurs in 4% of patients with GS at a mean 
age of 2.3 years [8]. Molecular targeted inhibitors of the hedgehog pathway have 
recently been developed to treat these tumors. Several small compounds have been 
applied to clinical trials for these tumors [9,10,11]. Of these, vismodegib (GDC-0449) 
was found to be the most effective inhibitor of SMO, reducing the number of BCCs [9].  
Since the hedgehog pathway has not yet been elucidated in detail in human cells, we 
herein investigated this signaling pathway in GS-derived dermal fibroblasts under 
diverse cellular stress conditions. 
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2. Material and Methods 
2.1. Materials 
   Recombinant human sonic hedgehog (shh) (C24II), N-Terminus (R&D Systems, 
Minneapolis, USA), smoothened agonist (SAG) (Calbiochem, Darmstadt, Germany), 
cyclopamine (BIOMOL, PA, USA), and vismodegib (GDC-0449) (Selleckchem, 
Huston, TX, USA) were purchased. Mouse monoclonal antibodies against human 
acetylated tubulin (Sigma-Aldrich, Saint Louis, MO, USA), anti-mouse IgG Alexa 594 
(Abcam, Cambridge, UK), and ‘4’,6-diamidini-2-phenylindole, dihydrochloride (DAPI) 
(Roche Diagnostics, Mannheim, Germany) were obtained. 
 
2.2. Human dermal fibroblasts 
All studies described below were approved by the local Ethics Committee of Chiba 
University. Human dermal fibroblasts were collected from three Japanese GS patients, 
who were from two families with PTCH1 mutations as an insertion in one family (G11 
and G12; c.3130_3131dupGC) and a deletion in one patient (G72 c.272delG). The ages 
of G11, G12, and G72 at dermal fibroblast collection were 14, 42, and 36 years old, 
respectively. After obtaining informed consent from GS patients, dermal specimens 
were collected from unaffected skin areas at the time of surgical operations. These 
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surgically resected dermal tissues were then cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal 
bovine serum (FBS) (Invitrogen), 1% penicillin, and 1% streptomycin. Fibroblasts were 
obtained from these dermal tissues, maintained at 37℃ in a humidified atmosphere 
(5% CO2 and 95% air), and seeded on 10-mm dishes. The culture medium was renewed 
every 2 days until cellular confluence was achieved. Three origin-different normal 
human adult dermal fibroblasts were purchased (PCS-201-012; ATCC, Manassas, VA, 
USA). These fibroblasts were used during passages 4 to 8 in subsequent experiments. 
 
2.3. Stimulation with agonists and antagonists of the hedgehog pathway 
Fibroblasts were seeded on 12-well plates in DMEM with 10% FBS for 24hrs, the 
culture medium was renewed before stimulation experiments, and DMEM with 0.5% 
FBS was used for serum starvation. These fibroblasts were treated with human 
recombinant shh (1000ng/ml), cyclopamine (100nM), SAG (1μM), and vismodegib 
(10nM) for 48hrs after the medium change. 
 
2.4. Immunofluorescence and confocal microscopy 
Human fibroblasts grown on slide chambers were fixed with 4% paraformaldehyde. 
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Cells were washed with phosphate buffer saline (PBS) and permeabilized with 0.2% 
Triton X-100 in PBS, followed by blocking with 2% bovine serum albumin (BSA) in 
PBS for 1 hr at room temperature. Cells were incubated overnight at 4℃ with primary 
antibodies, diluted in 2% BSA in PBS, as mouse monoclonal anti-acetylated α-tubulin 
(1:1000). After washing with PBS, cells were incubated with secondary antibodies, 
anti-mouse IgG Alexa 594 (1:500), and DAPI (1:1000) for 30 min. Cells were viewed 
under a FLUOIVIEW FV1000-D/FV10i confocal microscope (OLYMPAS, Tokyo, 
Japan) and counted in at least 10 views. 
 
2.4. mRNA quantification by real-time PCR 
RNA was extracted from human dermal fibroblasts using the RNeasy Mini Kit 
(Qiagen, Hilden, Germany), and cDNA was synthesized with SuperScript Ⅲ First 
Strand Synthesis SuperMix (Invitrogen). PCR primers were designed against GLI1, 
GLI2, GLI3, PTCH1b, and SMO which are described in Table 1, and the reagent mix 
was incubated on the cycler (Bio-Rad, CA, USA) with normalization by the internal 
control gene human GAPDH. PCR reactions were run for 40 cycles twice in triplicate. 
The log-linear phase of amplification was monitored to obtain threshold cycle values. 
The comparative threshold cycle method was applied to determine expression levels. 
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The absence of primer dimers was verified by running the PCR product on a 1.5% 
agarose gel. To explore the relationships among hedgehog pathway components, we 
employed the RT2 Profiler PCR Array (Qiagen) and analyzed them by RT2 Profiler 
PCR Data Array analysis v3.5 
(http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php). 
 
2.5. Statistical analysis 
  Data were compared by a two-way ANOVA and Dunnett’s test using PRISM6 
(Graph Pad software). A P value less than 0.05 were considered significant. Data were 
shown as the mean ± the standard error of the mean (SEM). 
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3. Results 
3.1. Hedgehog signaling was enhanced in GS fibroblasts by shh with serum deprivation. 
   To establish the untreated status of hedgehog signaling in GS fibroblasts, we 
measured the mRNA levels of components of the hedgehog pathway: GLI1, GLI2, 
GLI3, PTCH1b, and SMO, using real-time PCR. Before the treatment with shh, GLI1 
mRNA levels were more than 3-fold higher in GS fibroblasts than in the controls 
(Figure 1A). The expression levels of SMO mRNA were also 2-fold higher in GS 
fibroblasts than in the controls. No significant differences were observed in the mRNA 
levels of the other hedgehog pathway components between GS fibroblasts and the 
controls. Although GLI mRNA levels were elevated in all GS fibroblasts, individually 
different activated levels were observed in each GS cell. For example, GLI1 levels were 
elevated less in G12 fibroblasts than in other GS fibroblasts. 
We then investigated the influence of shh on GS fibroblasts in order to determine 
whether this condition represented tumorigenesis in GS patients. The sole stimulation of 
the hedgehog protein did not enhance GLI1 mRNA levels above those in the controls 
(Figure 1B). 
Since the number of ciliated cells has been shown to increase with nutritional 
deprivation [12] and hedgehog signaling passes through these primary cilia, we starved 
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fibroblasts and treated them with or without shh. The stimulation of shh and serum 
deprivation markedly elevated GLI1 levels by at least 3-fold those in the controls 
(Figure 1B). GLI1 mRNA levels were lower in G12 fibroblasts than in other GS 
fibroblasts under the untreated condition; however, these levels were significantly 
increased by the shh stimulation. These results suggested that GLI1 mRNA levels were 
constitutively higher in all GS fibroblasts than in the controls, and that hedgehog 
signaling was synergistically activated by shh stimulation and serum deprivation. 
 
3.2. Formation of primary cilia was increased after serum starvation 
We examined the formation of primary cilia by GS fibroblasts and controls using 
immunostaining for primary cilia and counted the number of ciliated cells (Figure 2A). 
The percentage of ciliated cells was increased by serum starvation in both GS 
fibroblasts and controls (Figure 2B). Under the condition of serum starvation, the 
additional shh stimulation did not increase the number of ciliated cells (Figure 2C). 
These results suggested that GS fibroblasts as well as control fibroblasts have the ability 
to form cilia under nutritional deprivation. 
 
3.3. Cyclopamine and vismodegib reduced shh-induced elevations in GLI1 levels in GS 
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fibroblasts 
To investigate the effects of hedgehog pathway activators and inhibitors on human 
fibroblasts, we used a SMO agonist (SAG) and SMO inhibitors, such as cyclopamine 
and vismodegib. We initially treated fibroblasts with SAG, which increased the 
transcription levels of GLI1 more than by the shh treatment alone (Figure 3A). 
We next examined the effects of cyclopamine on GS fibroblasts. The shh-induced 
increase in Gli1 by shh was suppressed by cyclopamine to the levels observed under the 
untreated condition. On the other hand, no significant differences were observed in 
SMO mRNA levels between GS fibroblasts and the controls (Figure 3B).  
Vismodegib is a SMO inhibitor that has been used to treat basal cell carcinoma and 
medulloblastoma in clinical settings. To investigate the effects of the inhibition caused 
by this reagent, we treated GS fibroblasts and control cells with vismodegib and 
measured GLI1 mRNA levels. In GS fibroblasts, vismodegib markedly reduced the 
shh-induced expression of GLI1 mRNA (Figure 3C). 
Among the GLI1 levels observed, the reduction rates by cyclopamine and 
vismodegib were 44.5% and 53.7% in G11, 85.2% and 90.5% in G12, and 40.0% and 
66.8% in G72, respectively (Figure 3A, 3C). These results suggested that vismodegib 
was a more effective anti-cancer reagent in human fibroblasts than cyclopamine. In 
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these experiments, GS fibroblasts responded to shh and SAG more effectively than 
control cells, and vismodegib clearly inhibited the hedgehog pathway in GS fibroblasts. 
 
3.4. Molecular survey for identification of hedgehog-related genes  
   We detected different GLI1 mRNA levels between GS fibroblasts and normal 
controls in response to hedgehog pathway agonists and antagonists. To investigate the 
cause of these differences, we analyzed the expression levels of 84 hedgehog 
pathway-associated genes using a PCR array (Figure 4A). 
   Two-fold increases in expression levels between GS fibroblasts and control cells 
with both shh and serum deprivation were detected for GLI1, SMO, WNT8a (wingless 
8a), WNT9b, ZIC1 (zinc finger protein of the cerebellum 1), and ZIC2 (Figure 4B). 
These results suggested that the WNT pathway and ZIC may interact with the hedgehog 
pathway in human fibroblasts. On the other hand, 2-fold decreases in expression levels 
between GS fibroblasts and control cells were observed for BMP4 (bone morphogenetic 
protein 4), BMP8A, FGF9 (fibroblast growth factor 9), SFRP1, WNT16, and WNT2b 
(Figure 4C). Among these six genes, the expression of BMP4 was decreased the most 
by the stimulation of GS fibroblasts with shh. 
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4. Discussion 
We herein demonstrated that the GLI1 mRNA levels in dermal fibroblasts derived 
from patients with Gorlin syndrome were markedly increased. Hedgehog signaling was 
synergistically enhanced by hedgehog ligand binding and serum deprivation, and 
effectively blocked by the SMO inhibitor, vismodegib, which is already available on the 
market. These results revealed the distinctive usefulness of human dermal fibroblasts as 
a human specimen for examining hedgehog signal transduction, as well as mouse 
embryonic fibroblasts, and possibly evaluating the individual efficacies of molecular 
targeted therapies. 
Human fibroblasts are evolutionarily conserved mesenchymal cells that potentially 
express hedgehog pathway proteins. Since hedgehog signaling is relatively conserved in 
mouse embryonic fibroblasts, biological responses to hedgehog ligands have been 
thoroughly investigated. However, experiments using human dermal fibroblasts have 
been limited [13,14], and recent developments in molecular targeted therapies have 
necessitated the use of a tool to establish whether a drug will be useful as an anti-cancer 
treatment. Therefore, we employed human dermal fibroblasts in the present study. 
The most significant finding of this study was that hedgehog signaling in human 
fibroblasts was synergistically enhanced by hedgehog ligand binding and serum 
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deprivation. Given that hedgehog signaling is stimulated by the hedgehog protein, we 
treated human fibroblasts with the hedgehog protein under diverse conditions, resulting 
in the partial enhancement of the hedgehog pathway. However, the treatment of serum 
deprivation besides hedgehog binding markedly enhanced hedgehog signaling in GS 
fibroblasts. Thus, serum deprivation may potentially enhance hedgehog signaling in 
human tissues. 
   Primary cilia are a non-motile microtubule-based organelle that grows from the 
plasma membrane and functions in hedgehog signal transduction. In the absence of 
hedgehog, PTCH1 typically localizes to cilia and blocks the entry of SMO into primary 
cilia. However, in the presence of hedgehog, the inhibition by PTCH1 is released and 
SMO moves into primary cilia, resulting in signal activation [15,16,17]. Serum 
deprivation can induce the development of primary cilia, which has been associated 
with an increase in the number of ciliated cells [12]. Thus, we considered that the 
synergistic enhancement of hedgehog signaling may be transmitted via primary cilia. 
Since no significant difference was observed in the number of ciliated cells between GS 
fibroblasts and the controls, these enhancements in hedgehog signaling may have been 
due to novel mechanisms other than an increase in the number of ciliated cells.  
Previous studies have examined the relationship between serum starvation and 
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cancer treatments. In human mesothelioma, lung carcinoma, and colorectal carcinoma 
cell lines, serum starvation enhanced the effects of cisplatin by activating 
ATM/Chk2/p53 [18]. Furthermore, when pediatric brain tumor cells were exposed to 
chemotherapeutics under starvation stress, sensitivity to chemotherapy was elevated 
[19]. Thus, nutritional deprivation may also contribute to the treatment of cancer and 
growth of cancer cells.  
In our molecular survey for hedgehog-related genes, the expression of ZIC1 and 
ZIC2 were increased in the presence of both shh and serum deprivation. ZIC family 
proteins play an important role in neural development. In the early phase, in which the 
ectoderm differentiates into the neuroectoderm, ZIC controls the dorsal neural tube, 
while hedgehog controls the ventral one [20]. The dorsal expression of ZIC was shown 
to be regulated by sonic hedgehog as well as BMP4 and BMP7 [21]. The aberrant 
expression of ZIC1 and ZIC2 has been reported in some tumors, for example 
medulloblastoma and meningioma [22]. Interactions have also been detected between 
ZIC and GLI proteins through their zinc finger domains, suggesting that these 
interactions may depend on certain cell types [23, 24]. Thus, the results of our study 
suggested that ZIC and GLI systematically interacted and regulated cellular responses 
with each other in human fibroblasts. 
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In contrast, the expression of BMP4 was 10-fold lower in GS fibroblasts than in the 
controls in the presence of shh. BMP4, a member of the BMP family, plays important 
roles in embryogenesis and the development and maintenance of adult tissue 
homeostasis [25]. It has also been shown to inhibit the tumorigenicity of human 
glioblastoma cells in vitro, and may be a potential therapeutic agent [25,26]. These 
findings suggest that BMP4 is an alternative inhibitor of the hedgehog pathway and can 
be used in the treatment of hedgehog-related tumors. 
There were limitations to this study. Different hedgehog activity levels were 
observed among the GS patients who participated in this study. We attributed this to the 
limitation of human primary fibroblasts. G12 fibroblasts had higher GLI1 mRNA levels 
and better responses to the Shh stimulation than the controls; however, these levels were 
lower than those of other GS fibroblasts. Given that human primary cells generally have 
a limited capacity for proliferation in cultures, this phenomenon may be related to 
reductions in telomere lengths [27]. Moreover, an inverse relationship has been reported 
between donor age and telomere length in dermal fibroblasts [28]. Since G12 was older 
than the two other patients, we could not exclude the possibility of a decrease in the 
viability of the G12 fibroblasts. In this study, we only examined GS fibroblasts from 
three patients; therefore, further investigations are needed to elucidate the mechanism 
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underlying these synergistically enhancements in human GS fibroblasts. 
   Our results suggest that hedgehog signaling is constantly activated in Gorlin 
syndrome fibroblasts. Given that this signaling is synergistically enhanced by ligand 
hedgehog binding and serum deprivation, inhibitors of the pathway with starvation may 
be applied as alternative therapeutic approaches for the treatment of Gorlin syndrome in 
the future. 
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Table 1    Primers used for real-time PCR 
 
Probe Forward primer (5´ to 3´)  
Reverse primer (5´ to 3´) 
Annealing 
temperature (°C) 
Length  
(bp) 
GLI1 AGGGAGTGCAGCCAATACAG 
ATTGGCCGGAGTTGATGTAG 
64 171 
GLI2 AGCAGCAGCAACTGTCTGAGTGA 
GACCTTGCTGCGCTTGTGAA 
60 105 
GLI3 TCCAACACAGAGGCCTATTCCAG 
CTCTTGTTGTGCATCGGGTCA 
60 141 
PTCH1b ACCAGAATGGGTCCACGACAA 
AAAGTCTGAGGTGTCCCGCAA 
60 127 
SMO GCCATGTTTGGAACTGGCATC 
ATCCGCTTTGGCTCATCGTC 
58 119 
GAPDH GAGTCAACGGATTTGGTCGT 
GACAAGCTTCCCGTTCTCAG 
58 185 
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Fig. 1 Hedgehog signaling was activated in fibroblasts derived from patients with 
Gorlin syndrome. (A) The relative expression of the mRNA of hedgehog 
pathway-related proteins in control fibroblasts (Ctrls) and Gorlin syndrome 
fibroblasts (G11, G12, G72). (B) The relative expression of Gli1mRNA (mean ± 
SEM; *P<0.05). 
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Fig. 2 The formation of primary cilia was increased after serum starvation in fibroblasts. 
(A) Immunostaining for primary cilia with acetylated tubulin (red) in GS fibroblasts 
without serum starvation and (B) 48hrs after serum removal. (C) Percentage of 
ciliated cells in control (Ctrl) and Gorlin syndrome (G-number) fibroblasts with 
(starvation-) or without serum (starvation+). (D) Percentage of ciliated cells with 
serum starvation and shh. 
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Fig. 3 Cyclopamine and 
vismodegib inhibited hedgehog 
signaling in GS fibroblasts. (A) 
The relative expression of GLI1 
mRNA in control fibroblasts 
(Ctrls) and Gorlin syndrome 
fibroblasts (G-number) under 
the condition of serum 
starvation and treatment with 
shh and/or cyclopamine (Cyc). 
(B) The relative expression 
levels of GLI1 mRNA under the 
serum deprivation condition and 
treatment with the SMO agonist 
(SAG) and/or cyclopamine.  
(C) The relative expression 
levels of Gli1 mRNA under 
serum deprivation conditions 
and treatment with shh and/or 
vismodegib (mean ± SEM; 
*P<0.05).  
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Fig. 4. Analysis of the transcription of hedgehog pathway-related proteins.  
(A) Scatterplots representing fold changes in mRNA levels in control fibroblasts and 
Gorlin syndrome fibroblasts under serum deprivation conditions with the shh treatment. 
Each circle shows a hedgehog-related gene. The central line represents no change; a 
circle above the central line shows a gene, the expression of which was increased: 
below shows a gene, the expression of which was decreased. Gray lines indicate 2-fold 
increases or decreases. (B) A table showing genes with expression levels that were 
increased by 2-fold and (C) decreased by 2-fold. 
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